HSU Ann,DONG Liang C',DING Amy,GUPTA Suneel,DONG Liang C
申请号：
IL24492016
公开号：
IL244920D0
申请日:
2016.04.05
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer； and (b) a decarboxylase inhibitor component.
